Patent · US Active

Compositions and methods for inhibition of the JAK pathway

US10479783B2 · kind B2 · utility

2Cited by
4References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 8, 2018
Grant dateNov 19, 2019
Priority date
Expiry dateFeb 8, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07B2200/05
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed are compounds of formula I, compositions containing them, and methods of use for the compounds and compositions in the treatment of conditions in which modulation of the JAK pathway or inhibition of JAK kinases, particularly JAK 2 and JAK3, are therapeutically useful. Also disclosed are methods of making the compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.